Atrium Health Lincoln/LCI-Lincolnton is a clinical research site located in Lincolnton, North Carolina, United States 28092.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Atrium Health Lincoln/LCI-Lincolnton has participated in 19 clinical trials with 17 currently active.
Therapeutic areas: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma.
Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Atrium Health Lincoln/LCI-Lincolnton has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Atrium Health Lincoln/LCI-Lincolnton has 19 clinical trials on record, with 17 currently active. Their work covers Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma.
Yes — Atrium Health Lincoln/LCI-Lincolnton holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.